APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Dutasteride Drug

Compare research editions
View pricing & licenses

Selected research

Industry Research

Dutasteride Drug Industry Research Report 2026

Report ID 173987060528 December 2025130 pages

Choose your research edition.

Industry ResearchDutasteride Drug Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Dutasteride Drug Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Dutasteride Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dutasteride Drug Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Dutasteride Drug Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Dutasteride Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Dutasteride Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Dutasteride Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Dutasteride Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Dutasteride Drug include GSK, Acella Pharmaceuticals, Amneal Pharmaceuticals, Ascent Pharmaceuticals, Aurobindo Pharma, Barr Pharmaceuticals, Chartwell, Endo and Strides Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Dutasteride Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Dutasteride Drug Market by Company

GSK

Acella Pharmaceuticals

Amneal Pharmaceuticals

Ascent Pharmaceuticals

Aurobindo Pharma

Barr Pharmaceuticals

Chartwell

Endo

Strides Pharma

Waylis Therapeutics

Zydus

Chengdu Suncadia Medicine

Jiangsu Wangao Pharmaceutical

Qilu Pharmaceutical

Humanwell Puracap

Sichuan Gowell Pharmaceutical

Dutasteride Drug Segment by Type

Single Drug

Combination Preparation

Dutasteride Drug Segment by Application

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Dutasteride Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dutasteride Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dutasteride Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dutasteride Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Dutasteride Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Dutasteride Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Dutasteride Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Dutasteride Drug Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Dutasteride Drug Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Dutasteride Drug Sales Market Share by Manufacturers (2021-2026) Table 8. Global Dutasteride Drug Revenue of Manufacturers (2021-2026) Table 9. Global Dutasteride Drug Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Dutasteride Drug Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Dutasteride Drug Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Dutasteride Drug, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Dutasteride Drug, Product Type & Application Table 14. Global Dutasteride Drug Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Dutasteride Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. GSK Company Information Table 19. GSK Business Overview Table 20. GSK Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. GSK Dutasteride Drug Product Portfolio Table 22. GSK Recent Developments Table 23. Acella Pharmaceuticals Company Information Table 24. Acella Pharmaceuticals Business Overview Table 25. Acella Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Acella Pharmaceuticals Dutasteride Drug Product Portfolio Table 27. Acella Pharmaceuticals Recent Developments Table 28. Amneal Pharmaceuticals Company Information Table 29. Amneal Pharmaceuticals Business Overview Table 30. Amneal Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Amneal Pharmaceuticals Dutasteride Drug Product Portfolio Table 32. Amneal Pharmaceuticals Recent Developments Table 33. Ascent Pharmaceuticals Company Information Table 34. Ascent Pharmaceuticals Business Overview Table 35. Ascent Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Ascent Pharmaceuticals Dutasteride Drug Product Portfolio Table 37. Ascent Pharmaceuticals Recent Developments Table 38. Aurobindo Pharma Company Information Table 39. Aurobindo Pharma Business Overview Table 40. Aurobindo Pharma Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Aurobindo Pharma Dutasteride Drug Product Portfolio Table 42. Aurobindo Pharma Recent Developments Table 43. Barr Pharmaceuticals Company Information Table 44. Barr Pharmaceuticals Business Overview Table 45. Barr Pharmaceuticals Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Barr Pharmaceuticals Dutasteride Drug Product Portfolio Table 47. Barr Pharmaceuticals Recent Developments Table 48. Chartwell Company Information Table 49. Chartwell Business Overview Table 50. Chartwell Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Chartwell Dutasteride Drug Product Portfolio Table 52. Chartwell Recent Developments Table 53. Endo Company Information Table 54. Endo Business Overview Table 55. Endo Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Endo Dutasteride Drug Product Portfolio Table 57. Endo Recent Developments Table 58. Strides Pharma Company Information Table 59. Strides Pharma Business Overview Table 60. Strides Pharma Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Strides Pharma Dutasteride Drug Product Portfolio Table 62. Strides Pharma Recent Developments Table 63. Waylis Therapeutics Company Information Table 64. Waylis Therapeutics Business Overview Table 65. Waylis Therapeutics Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Waylis Therapeutics Dutasteride Drug Product Portfolio Table 67. Waylis Therapeutics Recent Developments Table 68. Zydus Company Information Table 69. Zydus Business Overview Table 70. Zydus Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Zydus Dutasteride Drug Product Portfolio Table 72. Zydus Recent Developments Table 73. Chengdu Suncadia Medicine Company Information Table 74. Chengdu Suncadia Medicine Business Overview Table 75. Chengdu Suncadia Medicine Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Chengdu Suncadia Medicine Dutasteride Drug Product Portfolio Table 77. Chengdu Suncadia Medicine Recent Developments Table 78. Jiangsu Wangao Pharmaceutical Company Information Table 79. Jiangsu Wangao Pharmaceutical Business Overview Table 80. Jiangsu Wangao Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Jiangsu Wangao Pharmaceutical Dutasteride Drug Product Portfolio Table 82. Jiangsu Wangao Pharmaceutical Recent Developments Table 83. Qilu Pharmaceutical Company Information Table 84. Qilu Pharmaceutical Business Overview Table 85. Qilu Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Qilu Pharmaceutical Dutasteride Drug Product Portfolio Table 87. Qilu Pharmaceutical Recent Developments Table 88. Humanwell Puracap Company Information Table 89. Humanwell Puracap Business Overview Table 90. Humanwell Puracap Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Humanwell Puracap Dutasteride Drug Product Portfolio Table 92. Humanwell Puracap Recent Developments Table 93. Sichuan Gowell Pharmaceutical Company Information Table 94. Sichuan Gowell Pharmaceutical Business Overview Table 95. Sichuan Gowell Pharmaceutical Dutasteride Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sichuan Gowell Pharmaceutical Dutasteride Drug Product Portfolio Table 97. Sichuan Gowell Pharmaceutical Recent Developments Table 98. Global Dutasteride Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Dutasteride Drug Sales by Region (2021-2026) & (K Units) Table 100. Global Dutasteride Drug Sales Market Share by Region (2021-2026) Table 101. Global Dutasteride Drug Sales by Region (2027-2032) & (K Units) Table 102. Global Dutasteride Drug Sales Market Share by Region (2027-2032) Table 103. Global Dutasteride Drug Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Dutasteride Drug Revenue Market Share by Region (2021-2026) Table 105. Global Dutasteride Drug Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Dutasteride Drug Revenue Market Share by Region (2027-2032) Table 107. North America Dutasteride Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 109. North America Dutasteride Drug Sales by Country (2027-2032) & (K Units) Table 110. North America Dutasteride Drug Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Dutasteride Drug Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Dutasteride Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 114. Europe Dutasteride Drug Sales by Country (2027-2032) & (K Units) Table 115. Europe Dutasteride Drug Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Dutasteride Drug Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Dutasteride Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 119. Asia Pacific Dutasteride Drug Sales by Country (2027-2032) & (K Units) Table 120. Asia Pacific Dutasteride Drug Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Dutasteride Drug Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Dutasteride Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 124. South America Dutasteride Drug Sales by Country (2027-2032) & (K Units) Table 125. South America Dutasteride Drug Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Dutasteride Drug Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Dutasteride Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Dutasteride Drug Sales by Country (2021-2026) & (K Units) Table 129. Middle East and Africa Dutasteride Drug Sales by Country (2027-2032) & (K Units) Table 130. Middle East and Africa Dutasteride Drug Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Dutasteride Drug Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Dutasteride Drug Sales by Type (2021-2026) & (K Units) Table 133. Global Dutasteride Drug Sales by Type (2027-2032) & (K Units) Table 134. Global Dutasteride Drug Sales Market Share by Type (2021-2026) Table 135. Global Dutasteride Drug Sales Market Share by Type (2027-2032) Table 136. Global Dutasteride Drug Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Dutasteride Drug Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Dutasteride Drug Revenue Market Share by Type (2021-2026) Table 139. Global Dutasteride Drug Revenue Market Share by Type (2027-2032) Table 140. Global Dutasteride Drug Price by Type (2021-2026) & (US$/Unit) Table 141. Global Dutasteride Drug Price by Type (2027-2032) & (US$/Unit) Table 142. Global Dutasteride Drug Sales by Application (2021-2026) & (K Units) Table 143. Global Dutasteride Drug Sales by Application (2027-2032) & (K Units) Table 144. Global Dutasteride Drug Sales Market Share by Application (2021-2026) Table 145. Global Dutasteride Drug Sales Market Share by Application (2027-2032) Table 146. Global Dutasteride Drug Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Dutasteride Drug Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Dutasteride Drug Revenue Market Share by Application (2021-2026) Table 149. Global Dutasteride Drug Revenue Market Share by Application (2027-2032) Table 150. Global Dutasteride Drug Price by Application (2021-2026) & (US$/Unit) Table 151. Global Dutasteride Drug Price by Application (2027-2032) & (US$/Unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Dutasteride Drug Distributors List Table 155. Dutasteride Drug Customers List Table 156. Dutasteride Drug Industry Trends Table 157. Dutasteride Drug Industry Drivers Table 158. Dutasteride Drug Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Dutasteride Drug Product Image Figure 5. Global Dutasteride Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Dutasteride Drug Market Size (2021-2032) & (US$ Million) Figure 7. Global Dutasteride Drug Sales (2021-2032) & (K Units) Figure 8. Global Dutasteride Drug Average Price (US$/Unit) & (2021-2032) Figure 9. Single Drug Product Image Figure 10. Combination Preparation Product Image Figure 11. Retail Pharmacy Product Image Figure 12. Hospital Pharmacy Product Image Figure 13. Online Pharmacy Product Image Figure 14. Global Dutasteride Drug Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Dutasteride Drug, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Dutasteride Drug Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Dutasteride Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Dutasteride Drug Sales by Region in 2025 Figure 20. Global Dutasteride Drug Revenue by Region in 2025 Figure 21. North America Dutasteride Drug Market Size by Country in 2025 Figure 22. North America Dutasteride Drug Sales Market Share by Country (2021-2032) Figure 23. North America Dutasteride Drug Revenue Market Share by Country (2021-2032) Figure 24. United States Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Dutasteride Drug Market Size by Country in 2025 Figure 28. Europe Dutasteride Drug Sales Market Share by Country (2021-2032) Figure 29. Europe Dutasteride Drug Revenue Market Share by Country (2021-2032) Figure 30. Germany Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Dutasteride Drug Market Size by Country in 2025 Figure 41. Asia Pacific Dutasteride Drug Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Dutasteride Drug Revenue Market Share by Country (2021-2032) Figure 43. China Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Dutasteride Drug Market Size by Country in 2025 Figure 52. South America Dutasteride Drug Sales Market Share by Country (2021-2032) Figure 53. South America Dutasteride Drug Revenue Market Share by Country (2021-2032) Figure 54. Brazil Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Dutasteride Drug Market Size by Country in 2025 Figure 58. Middle East and Africa Dutasteride Drug Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Dutasteride Drug Revenue Market Share by Country (2021-2032) Figure 60. Egypt Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Dutasteride Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Dutasteride Drug Sales Market Share by Type (2021-2032) Figure 66. Global Dutasteride Drug Revenue Market Share by Type (2021-2032) Figure 67. Global Dutasteride Drug Price (US$/Unit) by Type (2021-2032) Figure 68. Global Dutasteride Drug Sales Market Share by Application (2021-2032) Figure 69. Global Dutasteride Drug Revenue Market Share by Application (2021-2032) Figure 70. Global Dutasteride Drug Price (US$/Unit) by Application (2021-2032) Figure 71. Dutasteride Drug Value Chain Figure 72. Dutasteride Drug Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Dutasteride Drug Industry Opportunities and Challenges

Scope & coverage.

Types
  • Single Drug
  • Combination Preparation
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Companies covered
  • GSK
  • Acella Pharmaceuticals
  • Amneal Pharmaceuticals
  • Ascent Pharmaceuticals
  • Aurobindo Pharma
  • Barr Pharmaceuticals
  • Chartwell
  • Endo
  • Strides Pharma
  • Waylis Therapeutics
  • Zydus
  • Chengdu Suncadia Medicine
  • Jiangsu Wangao Pharmaceutical
  • Qilu Pharmaceutical
  • Humanwell Puracap
  • Sichuan Gowell Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Dutasteride Drug Market Size (2021-2032)
  4. 2.2.2 Global Dutasteride Drug Sales (2021-2032)
  5. 2.2.3 Global Dutasteride Drug Market Average Price (2021-2032)
  6. 2.3 Dutasteride Drug by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Single Drug
  9. 2.3.3 Combination Preparation
  10. 2.4 Dutasteride Drug by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Retail Pharmacy
  13. 2.4.3 Hospital Pharmacy
  14. 2.4.4 Online Pharmacy
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Dutasteride Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Dutasteride Drug Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Dutasteride Drug Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Dutasteride Drug Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Dutasteride Drug Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Dutasteride Drug, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Dutasteride Drug, Product Type & Application
  8. 3.8 Global Manufacturers of Dutasteride Drug, Established Date
  9. 3.9 Global Dutasteride Drug Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 GSK
  2. 4.1.1 GSK Company Information
  3. 4.1.2 GSK Business Overview
  4. 4.1.3 GSK Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 GSK Dutasteride Drug Product Portfolio
  6. 4.1.5 GSK Recent Developments
  7. 4.2 Acella Pharmaceuticals
  8. 4.2.1 Acella Pharmaceuticals Company Information
  9. 4.2.2 Acella Pharmaceuticals Business Overview
  10. 4.2.3 Acella Pharmaceuticals Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Acella Pharmaceuticals Dutasteride Drug Product Portfolio
  12. 4.2.5 Acella Pharmaceuticals Recent Developments
  13. 4.3 Amneal Pharmaceuticals
  14. 4.3.1 Amneal Pharmaceuticals Company Information
  15. 4.3.2 Amneal Pharmaceuticals Business Overview
  16. 4.3.3 Amneal Pharmaceuticals Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Amneal Pharmaceuticals Dutasteride Drug Product Portfolio
  18. 4.3.5 Amneal Pharmaceuticals Recent Developments
  19. 4.4 Ascent Pharmaceuticals
  20. 4.4.1 Ascent Pharmaceuticals Company Information
  21. 4.4.2 Ascent Pharmaceuticals Business Overview
  22. 4.4.3 Ascent Pharmaceuticals Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Ascent Pharmaceuticals Dutasteride Drug Product Portfolio
  24. 4.4.5 Ascent Pharmaceuticals Recent Developments
  25. 4.5 Aurobindo Pharma
  26. 4.5.1 Aurobindo Pharma Company Information
  27. 4.5.2 Aurobindo Pharma Business Overview
  28. 4.5.3 Aurobindo Pharma Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Aurobindo Pharma Dutasteride Drug Product Portfolio
  30. 4.5.5 Aurobindo Pharma Recent Developments
  31. 4.6 Barr Pharmaceuticals
  32. 4.6.1 Barr Pharmaceuticals Company Information
  33. 4.6.2 Barr Pharmaceuticals Business Overview
  34. 4.6.3 Barr Pharmaceuticals Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Barr Pharmaceuticals Dutasteride Drug Product Portfolio
  36. 4.6.5 Barr Pharmaceuticals Recent Developments
  37. 4.7 Chartwell
  38. 4.7.1 Chartwell Company Information
  39. 4.7.2 Chartwell Business Overview
  40. 4.7.3 Chartwell Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Chartwell Dutasteride Drug Product Portfolio
  42. 4.7.5 Chartwell Recent Developments
  43. 4.8 Endo
  44. 4.8.1 Endo Company Information
  45. 4.8.2 Endo Business Overview
  46. 4.8.3 Endo Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Endo Dutasteride Drug Product Portfolio
  48. 4.8.5 Endo Recent Developments
  49. 4.9 Strides Pharma
  50. 4.9.1 Strides Pharma Company Information
  51. 4.9.2 Strides Pharma Business Overview
  52. 4.9.3 Strides Pharma Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Strides Pharma Dutasteride Drug Product Portfolio
  54. 4.9.5 Strides Pharma Recent Developments
  55. 4.10 Waylis Therapeutics
  56. 4.10.1 Waylis Therapeutics Company Information
  57. 4.10.2 Waylis Therapeutics Business Overview
  58. 4.10.3 Waylis Therapeutics Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Waylis Therapeutics Dutasteride Drug Product Portfolio
  60. 4.10.5 Waylis Therapeutics Recent Developments
  61. 4.11 Zydus
  62. 4.11.1 Zydus Company Information
  63. 4.11.2 Zydus Business Overview
  64. 4.11.3 Zydus Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Zydus Dutasteride Drug Product Portfolio
  66. 4.11.5 Zydus Recent Developments
  67. 4.12 Chengdu Suncadia Medicine
  68. 4.12.1 Chengdu Suncadia Medicine Company Information
  69. 4.12.2 Chengdu Suncadia Medicine Business Overview
  70. 4.12.3 Chengdu Suncadia Medicine Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Chengdu Suncadia Medicine Dutasteride Drug Product Portfolio
  72. 4.12.5 Chengdu Suncadia Medicine Recent Developments
  73. 4.13 Jiangsu Wangao Pharmaceutical
  74. 4.13.1 Jiangsu Wangao Pharmaceutical Company Information
  75. 4.13.2 Jiangsu Wangao Pharmaceutical Business Overview
  76. 4.13.3 Jiangsu Wangao Pharmaceutical Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Jiangsu Wangao Pharmaceutical Dutasteride Drug Product Portfolio
  78. 4.13.5 Jiangsu Wangao Pharmaceutical Recent Developments
  79. 4.14 Qilu Pharmaceutical
  80. 4.14.1 Qilu Pharmaceutical Company Information
  81. 4.14.2 Qilu Pharmaceutical Business Overview
  82. 4.14.3 Qilu Pharmaceutical Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Qilu Pharmaceutical Dutasteride Drug Product Portfolio
  84. 4.14.5 Qilu Pharmaceutical Recent Developments
  85. 4.15 Humanwell Puracap
  86. 4.15.1 Humanwell Puracap Company Information
  87. 4.15.2 Humanwell Puracap Business Overview
  88. 4.15.3 Humanwell Puracap Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Humanwell Puracap Dutasteride Drug Product Portfolio
  90. 4.15.5 Humanwell Puracap Recent Developments
  91. 4.16 Sichuan Gowell Pharmaceutical
  92. 4.16.1 Sichuan Gowell Pharmaceutical Company Information
  93. 4.16.2 Sichuan Gowell Pharmaceutical Business Overview
  94. 4.16.3 Sichuan Gowell Pharmaceutical Dutasteride Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Sichuan Gowell Pharmaceutical Dutasteride Drug Product Portfolio
  96. 4.16.5 Sichuan Gowell Pharmaceutical Recent Developments
5 Global Dutasteride Drug Market Scenario by Region
  1. 5.1 Global Dutasteride Drug Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Dutasteride Drug Sales by Region: 2021-2032
  3. 5.2.1 Global Dutasteride Drug Sales by Region: 2021-2026
  4. 5.2.2 Global Dutasteride Drug Sales by Region: 2027-2032
  5. 5.3 Global Dutasteride Drug Revenue by Region: 2021-2032
  6. 5.3.1 Global Dutasteride Drug Revenue by Region: 2021-2026
  7. 5.3.2 Global Dutasteride Drug Revenue by Region: 2027-2032
  8. 5.4 North America Dutasteride Drug Market Facts & Figures by Country
  9. 5.4.1 North America Dutasteride Drug Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Dutasteride Drug Sales by Country (2021-2032)
  11. 5.4.3 North America Dutasteride Drug Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Dutasteride Drug Market Facts & Figures by Country
  16. 5.5.1 Europe Dutasteride Drug Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Dutasteride Drug Sales by Country (2021-2032)
  18. 5.5.3 Europe Dutasteride Drug Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Dutasteride Drug Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Dutasteride Drug Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Dutasteride Drug Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Dutasteride Drug Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Dutasteride Drug Market Facts & Figures by Country
  41. 5.7.1 South America Dutasteride Drug Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Dutasteride Drug Sales by Country (2021-2032)
  43. 5.7.3 South America Dutasteride Drug Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Dutasteride Drug Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Dutasteride Drug Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Dutasteride Drug Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Dutasteride Drug Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Dutasteride Drug Sales by Type (2021-2032)
  2. 6.1.1 Global Dutasteride Drug Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Dutasteride Drug Sales Market Share by Type (2021-2032)
  4. 6.2 Global Dutasteride Drug Revenue by Type (2021-2032)
  5. 6.2.1 Global Dutasteride Drug Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Dutasteride Drug Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Dutasteride Drug Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Dutasteride Drug Sales by Application (2021-2032)
  2. 7.1.1 Global Dutasteride Drug Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Dutasteride Drug Sales Market Share by Application (2021-2032)
  4. 7.2 Global Dutasteride Drug Revenue by Application (2021-2032)
  5. 7.2.1 Global Dutasteride Drug Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Dutasteride Drug Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Dutasteride Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Dutasteride Drug Value Chain Analysis
  2. 8.1.1 Dutasteride Drug Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Dutasteride Drug Production Mode & Process
  5. 8.2 Dutasteride Drug Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Dutasteride Drug Distributors
  8. 8.2.3 Dutasteride Drug Customers
9 Global Dutasteride Drug Analyzing Market Dynamics
  1. 9.1 Dutasteride Drug Industry Trends
  2. 9.2 Dutasteride Drug Industry Drivers
  3. 9.3 Dutasteride Drug Industry Opportunities and Challenges
  4. 9.4 Dutasteride Drug Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst